Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin Leakage
Lintao Wang, Qian Chen, Hai-Xia Qi, et al.
Cancer Research (2016) Vol. 76, Iss. 22, pp. 6631-6642
Open Access | Times Cited: 150

Showing 26-50 of 150 citing articles:

Glabridin Prevents Doxorubicin-Induced Cardiotoxicity Through Gut Microbiota Modulation and Colonic Macrophage Polarization in Mice
Keqing Huang, Yanzhuo Liu, Honglin Tang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 57
Nicorandil combats doxorubicin–induced nephrotoxicity via amendment of TLR4/P38 MAPK/NFκ-B signaling pathway
Ali Khames, Marwa M. Khalaf, Amany M. Gad, et al.
Chemico-Biological Interactions (2019) Vol. 311, pp. 108777-108777
Closed Access | Times Cited: 56
Genistein protects against doxorubicin‐induced cardiotoxicity through Nrf‐2/HO‐1 signaling in mice model
Bai Zhifeng, Zhijian Wang
Environmental Toxicology (2019) Vol. 34, Iss. 5, pp. 645-651
Closed Access | Times Cited: 55
Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation
Carmine Rocca, Teresa Pasqua, Maria Carmela Cerra, et al.
Antioxidants and Redox Signaling (2020) Vol. 32, Iss. 15, pp. 1081-1097
Closed Access | Times Cited: 52
Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options
Fatemeh Yarmohammadi, Hedyieh Karbasforooshan, A. Wallace Hayes, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2003-2011
Closed Access | Times Cited: 45
Resveratrol reduces cardiac NLRP3‐inflammasome activation and systemic inflammation to lessen doxorubicin‐induced cardiotoxicity in juvenile mice
Zaid H. Maayah, Abrar S. Alam, Shingo Takahara, et al.
FEBS Letters (2021) Vol. 595, Iss. 12, pp. 1681-1695
Open Access | Times Cited: 42
Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer
Alaa Bawaneh, Adam S. Wilson, Nicole Levi, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4849-4849
Open Access | Times Cited: 35
Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity
Natticha Sumneang, Pongpan Tanajak, Thura Tun Oo
Molecules (2023) Vol. 28, Iss. 11, pp. 4294-4294
Open Access | Times Cited: 20
Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular Bioenergetics
Tamara E. Lacourt, Cobi J. Heijnen
Current Breast Cancer Reports (2017) Vol. 9, Iss. 2, pp. 70-81
Open Access | Times Cited: 51
Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration
C.V. Cardoso, Marcelo P. Barros, André Luís Lacerda Bachi, et al.
Behavioural Brain Research (2019) Vol. 378, pp. 112233-112233
Closed Access | Times Cited: 44
Biomarkers of inflammation, hypercoagulability and endothelial injury predict early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patients.
Valentina K. Todorova, Ping-Ching Hsu, Jeanne Y. Wei, et al.
PubMed (2020) Vol. 10, Iss. 9, pp. 2933-2945
Closed Access | Times Cited: 40
Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity
Sona Ciernikova, Michal Mego, Michal Chovanec
Cancers (2021) Vol. 13, Iss. 4, pp. 782-782
Open Access | Times Cited: 34
Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers
Karen Geoffroy, Bruna Araripe Saraiva, Mélissa Viens, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
The Gut–Heart Axis and Its Role in Doxorubicin-Induced Cardiotoxicity: A Narrative Review
Carolina Rodrigues Tonon, Amanda Gomes Pereira, Natália Fernanda Ferreira, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 855-855
Open Access
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
Heba Samy Shoukry, Hania Ibrahim Ammar, Laila Ahmed Rashed, et al.
PLoS ONE (2017) Vol. 12, Iss. 7, pp. e0181535-e0181535
Open Access | Times Cited: 45
<p>Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposure to Anthracyclines and Trastuzumab</p>
Vincenzo Quagliariello, Raffaele Vecchione, A Capua, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 4859-4876
Open Access | Times Cited: 36
Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
Elena Piegari, Anna Cozzolino, Loreta Pia Ciuffreda, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 33
Both‐In‐One Hybrid Bacteria Suppress the Tumor Metastasis and Relapse via Tandem‐Amplifying Reactive Oxygen Species‐Immunity Responses
Mengchi Sun, Hao Ye, Qinghua Shi, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 21
Closed Access | Times Cited: 30
Comparing the protective effects of resveratrol, curcumin and sulforaphane against LPS/IFN-γ-mediated inflammation in doxorubicin-treated macrophages
Haidy A. Saleh, Eman Ramdan, Mohamed M. Elmazar, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis
Wenliang Zha, Qian Zhao, Ye Xiao, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110736-110736
Closed Access | Times Cited: 12
Empagliflozin treatment of cardiotoxicity: A comprehensive review of clinical, immunobiological, neuroimmune, and therapeutic implications
Zahra Vaziri, Kiarash Saleki, Cena Aram, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115686-115686
Open Access | Times Cited: 12
Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations
Ahmed R. Hamed, Shaymaa M.M. Yahya, Heba K. Nabih
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 6, pp. 1117-1128
Open Access | Times Cited: 11
In Situ Implantation of Chitosan Oligosaccharide-Doped Lipoic Acid Hydrogel Breaks the “Vicious Cycle” of Inflammation and Residual Tumor Cell for Postoperative Skin Cancer Therapy
Mengqi Jia, Ruilin Lu, Caikun Liu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 27, pp. 32824-32838
Closed Access | Times Cited: 11
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Felix Sebastian Nettersheim, Johannes David Schlüter, Wiebke Kreuzberg, et al.
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 11
Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice
Ibrahim Y. Abdelgawad, Benu George, Marianne Grant, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 4, pp. 1191-1208
Closed Access | Times Cited: 4

Scroll to top